INTRODUCTION
Numerous signaling pathways are regulated by phosphorylation of target proteins, a phenomenon in which cyclic AMP (cAMP)-dependent protein kinase (PKA) plays a central role. Correct spatiotemporal localization of signaling molecules such as PKA is central to the intricacies of signal transduction. A family of proteins called the A-kinase-anchoring proteins (AKAPs) carries out this function for PKA, and characterization of PKA:AKAP complexes is thus important for understanding the mechanisms of regulation.
PKA is a homodimer of regulatory (R) subunits bound to two catalytic (C) subunits and, based on the R subunit, the enzyme is classified as type I or II (with a and b subclasses) (Skalhegg and Tasken, 1997) . Although all four R subunits share a similar domain organization, they are not functionally redundant and are localized differently in the cell. For example, RIa null mice are embryonically lethal, showing that its function is crucial for normal development (Amieux et al., 1997) . Mutations in the RIa gene cause familial cardiac myxomas and Carney complex (Casey et al., 2000; Kirschner et al., 2000) . Whereas RII subunits are localized to discrete parts of the cell, RI subunits are usually distributed diffusely in the cell (Wong and Scott, 2004) and then dynamically recruited to discrete sites such as the cap site of activated lymphocytes (Levy et al., 1996; Skalhegg et al., 1994) .
Each R subunit is composed of a dimerization/docking (D/D) domain at the N terminus followed by a linker containing an inhibitor site and, finally, two cAMP-binding domains ( Figure 1A ) (reviewed in Taylor et al., 2005) . The D/D domains form an X-type, antiparallel four-helix bundle that serves as a docking surface for AKAPs (Banky et al., 1998; Harris et al., 1994; Newlon et al., 2001) , which interact with the docking surface through an amphipathic helix (ca. 16 residues) (Banky et al., 1998; Gold et al., 2006; Kinderman et al., 2006; Newlon et al., 2001) . Whereas AKAPs were initially identified by their ability to bind RII subunits, in recent years several AKAPs such as D-AKAP1 (Huang et al., 1997b) , D-AKAP2 (Huang et al., 1997a) , AKAP220 (Reinton et al., 2000) , Merlin (Gronholm et al., 2003) , and Pap7 (Li et al., 2001) have been shown to bind RI subunits as well, thereby making them dual specific.
Dual-specific AKAP 2 (D-AKAP2) is a multisubunit protein containing two putative regulator of G protein signaling (RGS)-like homology domains, followed by a 27-residue PKA-binding (AKB) domain and finally a PSD-95/DlgA/ZO-1 (PDZ)-binding motif at the C terminus ( Figure 1B ) (Huang et al., 1997a) . The AKB domain of D-AKAP2 can bind to the D/D domains of both RI and RII with high affinity (K D = 48 and 2 nM, respectively) , showing that the motif has all the information necessary and sufficient for binding both R subunits.
The binding of the AKB region to R subunits has been characterized extensively using biochemical, biophysical, and structural methods. These include mutational studies of RI and RII to identify residues involved in dimerization and anchoring (Banky et al., 1998; , and hydrogen/deuterium exchange mass spectrometry (H/D MS) of RI and RII bound to the D-AKAP2 AKB to determine the regions that are protected upon binding (Burns-Hamuro et al., 2005) . Peptide arrays were used to determine RI versus RII specificity and design isoformspecific peptides to disrupt the PKA:AKAP interaction (Alto et al., 2003; Burns-Hamuro et al., 2003; Carlson et al., 2006; Gold et al., 2006) . Finally, single-nucleotide polymorphism (SNP) analyses showed that a single amino acid change (Val to Ile) in the AKB region results in reduced binding to RIa compared to RIIa and changes in the cellular distribution of RIa . This SNP is associated with myocardial infarction (Nishihama et al., 2007; Yoshida et al., 2007) , heart rate dysregulation (Tingley et al., 2007) , and familial breast cancer (Wirtenberger et al., 2007) .
The initial steps toward establishing a D/D domain:AKAP interaction were the NMR structure determinations of RIIa D/D (Newlon et al., 2001) and RIa D/D (Banky et al., 2003) . The two structures have a similar four-helix bundle organization, but unique to the RIa D/D domain is an N-terminal helix (named a0 or N-1 helix) that is stabilized by an intersubunit disulfide bond ( Figure 1A ). Although this helix is well formed, its position relative to the four-helix core is variable due to the flexibility of the a0-a1 loop (Banky et al., 2003) . Recently, it was also shown in cardiac myocytes that upon H 2 O 2 treatment there is increased disulfide-bond formation in the RIa D/D and nuclear localization of PKA, an effect attributed to the enhanced anchoring by AKAP (Brennan et al., 2006) . The presence of the N-terminal helix and the disulfide bonds in the RIa isoform begs the question: what roles do they play in anchoring AKAPs?
In order to further understand the molecular basis of AKAP anchoring, structures of RIIa D/D with D-AKAP2 (Kinderman et al., 2006) and with an RII-selective peptide, AKAP-IS (Gold et al., 2006) , were recently determined. Through an amphipathic helix, the asymmetric sequences of the AKAPs bind diagonally across the symmetric D/D domain. Interestingly, the N terminus of one monomer is ordered and makes critical interactions with the AKAP, whereas the N terminus of the other monomer is disordered. This flexibility was suggested to give the RII isoform the ability to bind a wider variety of AKAP sequences. The domain structures of RIa (A) and D-AKAP2 (B) are shown. In RI, the dimerization/docking (D/D) domain, inhibitor sequence, and the two cAMPbinding domains are labeled. In D-AKAP2, the RGS-like domains, A-kinase-binding (AKB) region, and C-terminal PDZ motif are indicated. The sequences of the RIa D/D domain and the D-AKAP2 AKB region used for crystallization are shown and numbered. Residues involved in a helices are indicated by a solid bar and every tenth residue is indicated by a dot. In RIa D/D, green and red stars indicate residues crucial for dimerization and docking to AKAP, respectively. The conserved Cys residues are highlighted in yellow. In D-AKAP2, residues not modeled and modeled as Ala in the structure are indicated in black and blue, respectively.
The RIIa D/D:D-AKAP2 structure was used to predict isoform differences of binding. For example, it was proposed that the disulfide-bonded Cys residues in RIa would be structurally equivalent to an Ile and Leu of RIIa and, therefore, would play equivalent roles in AKAP binding. Further, explanations for strong preferences for certain residues in D-AKAP2 for RIIa over RIa were also made based on a predicted RIa:D-AKAP2 binding. In summary, although these structures yielded important clues, the central question still remained: what are the structural determinants that render D-AKAP2 dual specific and AKAPs in general RI, RII, or dual specific?
To answer these questions and to complete the atomic-level picture of the dual specificity of D-AKAP2, we determined the crystal structures of the RIa D/D alone and in complex with the D-AKAP2 AKB. Extrapolating biochemical and biophysical data onto the structures allowed us to gain insights into the roles of the N-terminal helix and disulfide bonds in AKAP binding. An unexpected and novel finding is the shift in the helical register of D-AKAP2 when bound to RIa D/D relative to RIIa D/D. Although this result negates predictions made about AKAP binding to RIa, it now allows us to base all conclusions about isoform-specific AKAP binding on a strong structural foundation. A detailed comparison with the RIIa D/D:D-AKAP2 complex strongly suggests that this differential mode of binding to the PKA R subunits is true for all AKAPs.
RESULTS AND DISCUSSION
Overall Apo RIa D/D Structure Apo RIa D/D crystals contain a monomer in the asymmetric unit, with the obligatory homodimer generated by a crystallographic two-fold axis. Sulfur single-wavelength anomalous diffraction (SAD) data were used to carry out de novo phasing of the structure (Table 1) . To rationally compare the structure with existing D/D domain structures, the other half of the dimer was generated by a crystallographic transformation. As with other D/D domains, the RIa D/D dimer is composed of an X-type antiparallel, four-helix bundle with each monomer contributing two helices, a1 and a2, to the hydrophobic dimer interface (Figure 2A ) (Banky et al., 2003; Newlon et al., 2001 ). a0 at the N terminus also contributes to the dimer interface through two intermolecular disulfide bonds between Cys16 and Cys37 (Figures 2A and 2B) (Banky et al., 2003) . Tyr19 and Val20 stabilize the disulfide bond through packing interactions, and stacking interactions with His23, in turn, stabilize Tyr19 ( Figure 2A ) (see Figure S1A available online).
The intermolecular disulfides in the structure warrant a comment. Cys16 exists in two alternate conformations, with the major conformation being the oxidized disulfide conformation (0.7 occupancy; see Experimental Procedures) ( Figure 2B ). A control data set collected at the in-house X-ray source on the apo crystal shows an intact disulfide, thereby confirming that disulfide-bond cleavage is an artifact of synchrotron radiation (Table 1) . For this reason, we will treat it as a disulfide. In our model, therefore, one monomer forms two head-to-tail disulfides with a symmetry-generated monomer.
In general, the B factors of the core and the C terminus correlate well with previous backbone amide H/D MS experiments (Burns-Hamuro et al., 2005) . At the N terminus, Arg14 and Glu15 form salt bridges with Glu53 0 and Arg43 0 , respectively, via crystal-packing interactions (the ''prime'' symbol denotes symmetry-related residues), resulting in lower than average B factors (not shown). In solution and under oxidizing conditions, the disulfide bond would primarily stabilize the N-terminal region. This interpretation of the N-terminal helix is also consistent with the apo RIa D/D NMR structures ( Figure S1 ) (Banky et al., 2003) . (Diederichs and Karplus, 1997) . d Figure of merit (FOM) both before (SOLVE) and after (RESOLVE) density modification. e Ramachandran plot quality as defined in MolProbity (Lovell et al., 2003) .
interactions with the dimer. In the complex, RIa D/D is oxidized and maintains its four-helix bundle structure ( Figure 2C ). The N-terminal helices of both monomers are ordered and structurally similar to each other. The monomer whose N terminus interacts with the N terminus of D-AKAP2 is labeled ''A,'' and the other monomer is labeled ''B.'' Only residues from a0 and a1 play a role in stabilizing the D-AKAP2 binding. The root-meansquare deviation (rmsd) between the two RIa D/D monomers in the complex structure is $0.5 Å (49 equivalent Ca atoms), indicating that small differences exist. On the other hand, the rmsds between the dimer of the complex structure and apo structure are $1.4 Å (98 equivalent Ca atoms), suggesting that the organization of the two monomers undergoes rearrangements, mainly in the a0 and a1 regions, upon binding to D-AKAP2 ( Figure 2D ). For example, the side chains of Leu29 and Ile33 residues undergo large conformational changes to accommodate AKAP residues. Residues Gln26 and Lys30 present a different rotamer to make hydrogen bonds with residues Glu632, Asp645, and Gln649 of D-AKAP2, thereby stabilizing the helix.
Unlike the apo structure, the N and C termini of the RIa D/D and D-AKAP2 are not tethered artificially by crystal-packing interactions and are relatively more mobile, as indicated by their higher than average B factors ( Figure 2E ). Because the present structure is consistent with previous H/D MS experiments (Burns-Hamuro et al., 2005) , we can conclude that the structure is an accurate representation of how AKAPs interact with the RIa D/D domain.
Stabilizing Interactions
Although the same residues from each monomer are involved, high-affinity binding to D-AKAP2 is achieved by local specific changes in the D/D structure ( Figure 3A) . We describe the interaction interface in a systematic manner for three main reasons: first, to provide a context for the structural determinants of binding; second, to set the stage for comparing other D/D: AKAP complexes with the present structure; and finally, to provide a stable foundation for modeling other AKAPs onto the structure.
There are four main regions or pockets at the interface, pockets I-IV ( Figure 3 ). The residues of the D/D domain lining the pockets define the amino acids that can bind to the pockets and which residues are precluded. Correspondingly, binding specificity is achieved by the specific AKAP sequence that is bound to the pocket. This complementarity defines the specificity of the D/D domain:AKAP interaction. Figure 3C ). Ile642, in particular, fits very snugly into the hydrophobic pocket and is therefore likely to be a unique fit to the pocket. Pocket IV, occupied by Val646 and Met647 from the fifth turn of the AKAP helix, has similar residues lining it as pocket I. Unique to his pocket is the involvement of Cys37 A , the Cb atom of which packs against Val646. In contrast to pocket I, the residues in this pocket are not as tightly packed as compared to the other pockets and therefore would offer more flexibility in accommodating other residues ( Figure 3C ). For example, in order to accommodate Val646, Ile33
A undergoes a conformational change compared to the apo structure and to Ile33 B of the other monomer.
Additional hydrophobic interactions and salt bridges increase the stability of the interaction. Toward the N terminus, Trp636 makes hydrophobic interactions with the aliphatic chain of Lys30 B . Similarly, at the C terminus, Ala650 packs against 
Significance of the Disulfide Bond in AKAP Binding
Recently, Brennan et al. reported that treatment with H 2 O 2 resulted in increased disulfide formation and nuclear localization of PKA (Brennan et al., 2006) . The disulfide bond was suggested to play a role in the anchoring of AKAPs, which in turn promoted the increased nuclear localization. As mentioned earlier, the D/D dimer exists in the oxidized state in the complex and is, Amino acid replacement D-AKAP2 sequence Structure D-AKAP2 Anchoring of PKA RI Isoform therefore, a physiologically relevant AKAP-bound form. In order to understand the effect of the disulfide bond and other structurally close residues on AKAP binding, we have generated several mutants. Tyr19 and His23, which lie in close proximity to the disulfide bond, when mutated to Ala interfered with disulfide-bond formation without disrupting the dimer ( Figure 2B ; Figure S2 ). This is similar to the effects of mutating the two Cys residues to Ala (Banky et al., 1998) . The Y19A mutant protein is predominantly reduced and the H23A mutant exists as a mixture of reduced and oxidized proteins, suggesting that its role in maintaining disulfide-bond integrity is not as important as Tyr19 ( Figure S2 ). Tyrosines are often found to stabilize disulfide bonds, and our structure shows tight packing of the disulfide bond on the aromatic ring of Tyr19 (Petersen et al., 1999; Zauhar et al., 2000) .
Using fluorescence anisotropy experiments, the Cys16 and Cys37 mutants of RIa showed a 3-fold and a 16-fold reduction in binding to D-AKAP2 compared to the wild-type protein, respectively (Table 2) . On the other hand, the Y19A mutant showed a 27-fold decrease and the H23A mutant a 4-fold decrease in affinity. The fact that the Y19A mutant has the greatest effect on D-AKAP2 binding clearly suggests that its role in AKAP binding is greater than just disulfide stabilization. Disulfide-bond formation upon H 2 O 2 treatment would decrease the flexibility of the a0 helix relative to the core and, more importantly, would result in the assembly of pockets I and IV ( Figure 3C ). This assembly would partly be stabilized by Tyr19 and His23. This ordering of the pockets would position critical residues such as Leu13 and Cys16 in close proximity to the AKAP, resulting in improved binding of AKAPs to RIa.
Structure Confirms Biophysical and Biochemical Studies Mutational Data
Mutation of Val20 and Ile25 to Ala disrupts binding to AKAPs (Banky et al., 1998) . Val20 is part of pockets II and III and is therefore important for D-AKAP2 binding ( Figures 3A and 3B) . Interestingly, Ile25 does not directly interact with D-AKAP2. A comparison with the apo structure reveals that in order to accommodate D-AKAP2, Ile33 (pockets I and IV) undergoes a conformational change that is facilitated by a shift in the position of Ile25 ( Figure 3C ). Thus, an I25A mutation would disrupt the packing of Ile33, which in turn would disrupt the integrity of pockets I and IV. Peptide Array Information Peptide array analyses first highlighted the importance of the four turns of the helix for D-AKAP2 binding to the D/D domain of RIa , and our structure fully supports this conclusion. In general, there is decreased tolerance for mutations in pockets I, II, and III. Ala635, as noted earlier, is tightly nestled in pocket I, so that any mutation would result in disruption of binding. Indeed, this is confirmed by the peptide array, which shows that any mutation to the Ala635 position results in the loss of binding with RIa ( Figure 3C ). In pocket II, Ala639 can be changed only to a Val or an Ile ( Figure 3C ). The side chain of Trp636 packs against the AKAP helix, and the structure suggests that in its absence more changes could be tolerated at position 639 due to increased flexibility. The availability of structures allows us to deduce such correlated changes and also provides us with the ability to predict specificity for unknown AKAP peptides. Finally, the physiologically relevant Val646 to Ile SNP would result in a local shift of residues in order to accommodate the Cd1 atom, which would then pack against the disulfide bond. This change to Ile would be tolerated for binding but would likely result in a local disruption of the structure, leading to reduced affinity ( Figure 3C ).
In another study, Carlson and coworkers ) systematically mutated residues of a consensus sequence and tested it for RIa D/D binding. Three residues found to significantly increase binding to RIa compared to RIIa were Glu, Asp, and Ile, corresponding to positions occupied by Trp636, Ser644, and Val646, respectively, in D-AKAP2. Whereas Ile would make a hydrophobic interaction, the other two residues would be involved in stabilizing the helix through salt bridges or hydrogenbonding interactions with D/D domain residues. These data highlight the observation that the helix-stabilizing interactions, as well as the core hydrophobic interactions in pockets, are important for high-affinity binding of AKAPs to the RIa D/D domains.
Shift in the Helical Register Presents a Novel Interface for Binding
To deduce the isoform-specific differences of AKAP anchoring, in this study we compared the RIa D/D complex structure with Leu21 for the stabilization of the AKAP peptide. It was suggested that Ile3 and Leu21 play structurally equivalent roles to Cys16 and Cys37 in the RIa D/D structure (Gold et al., 2006; Kinderman et al., 2006) . From the present structure, it is evident that Cys37 is structurally similar to Leu21, as predicted. However, Cys16 is not spatially aligned with Ile3. The only residue that is spatially close to Ile3 is Leu13 from RIa D/D, although it does not make equivalent interactions with the AKAP (Figure 4C) . Thus, the present structure allows us to validate previous predictions made about the roles of RIa D/D residues in D-AKAP2 binding.
Basis for RI and RII Specificity
The specific and tight binding of AKAPs to the D/D domains is determined by the AKAP sequence and the spatial restrictions placed by the residues lining the pockets. Below, we describe the specific requirements for binding to R subunits and then propose a general model for AKAP binding to R subunits.
Requirements for RI and RII Binding
In pocket I of RIa D/D, any hydrophobic residue can replace position Leu634 of D-AKAP2, whereas Ala635 is a unique fit. In pocket II, residues Ile638 and Ala639 fit snugly in the space. Based on the structure, similar residues such as Leu or Val could replace Ile638. Peptide array analyses suggest that larger hydrophobic residues can also occupy this position. Either Val or Ile can replace Ala639, but the longer Leu side chain disrupts the pocket. The restricted space at position Ile642 in pocket III allows it to be replaced only by Val or a smaller amino acid such as an Ala. On the other hand, any hydrophobic residue can replace Val643. In pocket IV, only shorter-chain hydrophobic residues (Ile, Ala, and Leu) can occupy the Val646 position and nearly any residue can occupy the Met647 position ( Figure 4D ).
Based on the structure of the RIIa D/D:D-AKAP2 complex and peptide array analyses, spatial requirements of pockets I and II in RIIa are very stringent. In pocket I, the Ile638 position weakly tolerates Leu, Phe, or Val and the Ala639 position can tolerate a change to only Ile or Val. In pocket II, Ile642 and Val643 can tolerate a change to Val and Ile, respectively, or to Ala ( Figure 4D ). Consistency of Dual-, RI-, and RII-Specific AKAP Binding to R Subunits With the structure-based alignment of the D-AKAP2 sequence bound to RI and RII subunits and the AKAP sequence Residues that can replace the pocket residues without disrupting the interaction are shown above (for RIa) and below (for RIIa) the alignment in order of preference. (E-G) Alignment of dual-specific (E), RI-specific (F), and RII-specific (G) AKAPs to the aligned D-AKAP2 sequences according to their expected mode of binding to both RIa and RIIa. Dual-specific AKAPs satisfy the requirements for binding to both R subunits, whereas RI-or RII-specific AKAPs satisfy criteria for binding to RI or RII subunits.
requirements based on the properties of the pockets now established, the likelihood of a putative AKAP being RI, RII, or dual specific can now be predicted. Indeed, this model correctly identifies the specificity of previously established AKAPs. Further, it confirms that the differential binding of D-AKAP2 to RI and RII subunits is universal to all AKAPs.
An alignment of the AKB regions of two dual-specific AKAPs, D-AKAP1 (Huang et al., 1997b) and AKAP220 (Reinton et al., 2000) , with the D-AKAP2 sequence confirms that it matches the requirements of binding to both R subunits. For example, in RI binding, both AKAPs would have an Ala in position Ala635 of pocket I. In pocket II, position Ala639 would have an Ile and Val in D-AKAP1 and AKAP220, respectively. Finally, in pocket III, position Ile642 would be occupied by a Val and Ala in D-AKAP1 and AKAP220, respectively, both of which would be tolerated ( Figures 4D and 4E ). For RII binding, D-AKAP1 would present two Ile residues in pocket I and Val and Ile in pocket II. These residues would be very well tolerated in these pockets based on the structural and peptide array analyses. Similarly, in the case of AKAP220, Ile and Val (pocket I) and Ala and Ile (pocket II) would fulfill the requirements of binding to the RII subunit ( Figures 4D and 4E) .
RIAD, a peptide that has been shown to preferentially bind to RI, satisfies all the requirements for binding to the four RIa pockets . Although high-specificity binding to RI was achieved by a variety of peptides, three critical mutations made the peptide preferential for RI. Two residues mutated to acidic residues would contribute to the binding with RI through helix-stabilizing interactions. These mutations would disrupt the interaction with the RII subunit. For example, a mutation that results in an Asp residue in position K640 would be expected to make a hydrogen-bond interaction with Gln26 of RIa but would clash with a Thr residue in RIIa. Interestingly, within the core region of binding, RIAD satisfies the requirements of RIIa D/D binding ( Figures 4D and 4F) .
AKAP-IS binds specifically to RIIa and, as expected, fulfills the requirements of RII binding (Alto et al., 2003) (Figures 4D and  4G ). However, for RI binding, this peptide would present an Ile in position 635, a position that can tolerate only an Ala residue. Thus, it is not the specificity for RII subunits but rather the preclusion from RI binding that makes this peptide specific for RII subunits.
Strategy for Predicting the Specificity of an AKAP
The structures of RIa D/D:D-AKAP2 and RIIa D/D:D-AKAP2 now allow us to propose a strategy for deducing whether an AKAP is likely to be an RI-, RII-, or dual-specific AKAP. Because D-AKAP2 is the only AKAP whose structure is known with both R subunits, it can be used as a foundation for comparisons with putative AKAPs. The approach would be to first do a structure-based sequence alignment of the putative AKAP with the D-AKAP2 sequence in a fashion similar to that used in this study (Figure 4) . Based on the sequence alignment, it can be deduced whether the putative AKAP satisfies the requirements of RI and RII binding.
Because determinants in the core region for RII binding are fewer than for RI binding, consistency with the requirements do not necessarily imply binding. Thus, the second step would be to overlay the sequence onto the structures of RI and RII bound to D-AKAP2. This would be crucial for deciding whether residues outside the core-interacting regions would disrupt or enhance binding. As seen for the RIAD peptide, although the core requirements are fulfilled, an acidic residue outside the core region would be expected to disrupt RII binding. Similarly, as shown before, minor changes in the AKAP sequence could make it tolerant as seen in the case of Trp636 of D-AKAP2, the absence of which would make position Ala639 more tolerant to changes.
In summary, the structures presented here establish that a single AKAP peptide binds in a different mode to different R subunits. The shift in the a-helical register of D-AKAP2 also raises interesting questions about the evolution of AKAP sequences. Finally, as a general point, the register shift serves as a cautionary tale for predicting the mode of binding to homologous proteins.
EXPERIMENTAL PROCEDURES Protein Expression and Purification
Bovine full-length RIa was expressed and purified as described previously , and mutations were generated as described by Kunkel et al. (1987) . Bovine RIa D/D (residues 1-61) was expressed as described earlier (Banky et al., 2000) . Prior to purification, RIa D/D cells were suspended and lysed in 20 mM Tris (pH 8.0), 100 mM NaCl buffer containing protease inhibitors. The AKB region of human D-AKAP2 (residues 623-662) was cloned as a GST-tagged protein in pGEX 4T-1 vector with an internal thrombin cleavage site and expressed in a manner similar to RIa D/D.
Initial purification of His-RIa D/D was carried out using the Profinia protein purification system (Bio-Rad). Briefly, a preprogrammed method was used to bind the protein to an Ni-affinity column, followed by imidazole elution and a desalting step. Trypsin was used to cleave the His tag and first 11 residues of the protein and then separated by batch binding to benzamidine Sepharose 6B resin (GE Healthcare). As a final step, RIa D/D was purified by S75 gel filtration. The protein was concentrated to $30 mg/ml (3 280 nm = 4270 M À1 cm À1 ) for crystallization. GST-D-AKAP2 was first bound to glutathione Sepharose 4B resin (GE Healthcare) followed by cleavage of the tag. The resulting protein was purified on an S75 column and concentrated to $20 mg/ml (3 280 nm = 6970 M À1 cm À1 ).
For complex formation, equimolar quantities of RIa D/D dimer and D-AKAP2 were mixed and placed in ice for 30 min. The complex at a final concentration of $25 mg/ml was used for crystallization. For structure determination and refinement, data sets were collected using synchrotron and in-house sources and processed using HKL2000 (Table 1) (Otwinowski and Minor, 1997) . The apo RIa D/D structure was determined using the weak anomalous signal arising from inherently present sulfur atoms. The program SHELXD (Sheldrick, 2008) was used to locate the positions of the sulfurs. Heavy-atom refinement and phasing followed by density modification were performed using SOLVE/RESOLVE (Terwilliger and Berendzen, 1999 ).
Prior to model building and refinement, 10% of the data were set aside for cross-validation. The structure was built manually using the program Coot (Emsley and Cowtan, 2004) , and water molecules were placed manually using criteria described previously (Sarma et al., 2005) . Anisotropic TLS refinement as incorporated in PHENIX (Adams et al., 2002) followed by positional and individual B factor refinements resulted in a final R/R free of 18.7/24.9%. The final model has 50 residues, 29 waters, and 2 formate ions, with alternate conformations for Cys16 and Glu35. Alternate conformations were refined using various occupancies and the ones that yielded similar B factors for the two conformations were chosen.
The RIa D/D:D-AKAP2 complex structure was solved by molecular replacement using the program Phaser (McCoy et al., 2007) and the apo RIa D/D monomer (residues 23-61) as the search model. Initial F o -F c maps clearly showed the presence of the N-terminal residues and D-AKAP2. The residues were carefully built into maps resulting from the 2.3 Å data. Positional and individual B factor refinements were carried out using PHENIX (Adams et al., 2002) , with 10% of the reflections set aside for crossvalidation. With the two monomers and the AKB molecule treated as rigid bodies for TLS refinement, the structure was refined to a final R/R free of 18.6/25.4%. The final model includes 30 waters and 5 Zn 2+ ions. Occupancies for the 5 Zn 2+ ions were refined as described earlier (Sarma et al., 2005) and ranged from 0.4 to 1.0. Alternate conformations were modeled for Asn24 A and Cys16 B of RIa D/D.
Lys61
B of RIa D/D and D-AKAP2 residues 623-627 and 655-662 were not modeled due to weak density ( Figure 1B) . Additionally, five D-AKAP2 N-terminal residues that were part of the GST tag were also disordered. Lys22 A and Lys61 A of RIa D/D and Asp628, Gln631, Gln648, Gln651, Tyr652, and Gln654 in D-AKAP2 were modeled as Ala due to weak side-chain density ( Figure 1B) . Because waters are an integral part of structures, the solvent molecules in each structure were renumbered according to the strength of electron density, with water 1 being the highest. All structural figures were prepared using PyMOL (http://www.pymol.org).
Fluorescence Anisotropy Binding Assays
The 27-amino acid region from the D-AKAP2 AKB (residues 623-650) was synthesized and purified to greater than 95% purity by HPLC (Peptron). The last residue was changed to Cys for fluorescent labeling. The protein (0.5 mg) was incubated overnight with a 2-fold molar excess of fluorescein-5-maleimide or tetramethylrhodamine-5-maleimide (Molecular Probes). The labeled peptides were purified by HPLC and excess organic solvent was evaporated on a Speed Vac (Savant). Concentrations were determined using absorbance at 485 nm (3 485 nm = 90,000 M À1 cm À1 ) and 541 nm (3 541 nm = 91,000 M À1 cm À1 ) for the fluorescein-and rhodamine-labeled peptides, respectively. Binding studies with full-length and mutant proteins were carried out as previously described .
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